Inhibrx, Inc.

NASDAQ:INBX

12.15 (USD) • At close May 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016
Revenue 0.21.82.1787.12512.8089.0937.57.956.667
Cost of Revenue 2.2851.1912.8462.68873.49547.90733.45425.5116.992
Gross Profit -2.0850.609-0.6684.437-60.687-38.814-25.954-17.56-10.325
Gross Profit Ratio -10.4250.338-0.3070.623-4.738-4.269-3.461-2.209-1.549
Reseach & Development Expenses 203.743190.648110.18671.4473.49547.90733.45425.5116.992
General & Administrative Expenses 127.90529.38121.12312.3556.8369.0184.6542.6091.821
Selling & Marketing Expenses 00000000-0.253
SG&A 127.90529.38121.12312.3556.8369.0184.6542.6091.568
Other Expenses 00-0.014-0.106-0.08-4.1180.0680.0240
Operating Expenses 331.648219.83131.29583.68980.25152.80737.01327.67818.56
Operating Income -331.448-219.221-129.117-76.564-67.443-43.714-29.513-19.728-12.146
Operating Income Ratio -1,657.24-121.789-59.282-10.746-5.266-4.807-3.935-2.482-1.822
Total Other Income Expenses Net 2,019.022-20.503-29.9-5.202-8.191-6.788-1.412-2.102-0.739
Income Before Tax 1,687.574-239.724-145.223-81.766-75.634-50.502-30.925-21.83-12.885
Income Before Tax Ratio 8,437.87-133.18-66.677-11.476-5.905-5.554-4.123-2.746-1.933
Income Tax Expense 0.0020.0030.0030.0020.0030.8980.0960.25-4.616
Net Income 1,687.572-241.361-145.226-81.768-75.637-51.4-31.163-19.442-8.269
Net Income Ratio 8,437.86-134.089-66.679-11.476-5.905-5.653-4.155-2.446-1.24
EPS 114.01-5.12-3.62-2.15-2.99-1.41-1.15-0.68-0.23
EPS Diluted 112.62-5.12-3.62-2.15-2.99-1.41-1.15-0.68-0.23
EBITDA 1,703.35-206.693-125.817-76.564-67.443-42.604-28.769-19.305-11.893
EBITDA Ratio 8,516.75-114.829-57.767-10.746-5.266-4.685-3.836-2.428-1.784